Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Onyx BiotecNSE:ONYX -1.97%16 3-1 Month Momentum % is 15.82% as of Sep. 21, 2026. GuruFocus rates NSE:ONYX with a GF Score™ of 16/100. The stock has 6 warning signs investors should review. Among 847 Medical Devices & Instruments companies, Onyx Biotec ranks better than 81.11% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-21), Onyx Biotec's 3-1 Month Momentum % is 15.82%.
The industry rank for Onyx Biotec's 3-1 Month Momentum % or its related term are showing as below:
NSE:ONYX's 3-1 Month Momentum % is ranked better than 81.11% of 847
companies
in the Medical Devices & Instruments industry
Industry Median: 0.61
vs NSE:ONYX: 15.82
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Onyx Biotec 3-1 Month Momentum % Related Terms
NSE:ONYX vs ISRG, BDX, RMD: 3-1 Month Momentum % Comparison
For the Medical Instruments & Supplies subindustry, Onyx Biotec's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Biotec 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Onyx Biotec's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Onyx Biotec's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onyx Biotec (NSE:ONYX) has a 3-1 Month Momentum % of 15.82% as of Sep. 21, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Onyx Biotec and its competitors. According to the industry distribution chart, Onyx Biotec ranks #160 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 18.9%.
Is Onyx Biotec's 3-1 Month Momentum % too high?
Onyx Biotec's current 3-1 Month Momentum % is 15.82%. The Medical Devices & Instruments industry median 3-1 Month Momentum % is 0.61. Onyx Biotec's value of 15.82% is 2493.4% above this industry median. Based on the distribution chart, Onyx Biotec ranks #160 out of 847 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Onyx Biotec has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's 3-1 Month Momentum % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Onyx Biotec ranks #160 out of 847 companies for 3-1 Month Momentum %. This places Onyx Biotec in the top 19% of its industry — outperforming the majority of peers. The industry median 3-1 Month Momentum % is 0.61. Onyx Biotec's value of 15.82% is 2493.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
The median 3-1 Month Momentum % among Medical Devices & Instruments companies is 0.61, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Biotec's current 3-1 Month Momentum % of 15.82% is 2493.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Onyx Biotec and its competitors. For the Medical Devices & Instruments industry, the median 3-1 Month Momentum % is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Biotec's current 3-1 Month Momentum % is 15.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current 3-1 Month Momentum % of 15.82%. The current 3-1 Month Momentum % is 15.82% and 2493.4% above the Medical Devices & Instruments industry median of 0.61. Onyx Biotec's overall GF Score™ is 16/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current 3-1 Month Momentum % is 15.82% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
16GF Score
Get the complete analysis for NSE:ONYX
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ONYX has been successfully added to your 
